Skip to main content
Erschienen in: Journal of Nanoparticle Research 5/2010

01.06.2010 | Research Paper

Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells

verfasst von: Amanda L. Martin, Jennifer L. Hickey, Amber L. Ablack, John D. Lewis, Leonard G. Luyt, Elizabeth R. Gillies

Erschienen in: Journal of Nanoparticle Research | Ausgabe 5/2010

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The imaging of molecular markers associated with disease offers the possibility for earlier detection and improved treatment monitoring. Receptors for gastrin-releasing peptide are overexpressed on prostate cancer cells offering a promising imaging target, and analogs of bombesin, an amphibian tetradecapeptide have been previously demonstrated to target these receptors. Therefore, the pan-bombesin analog [β-Ala11, Phe13, Nle14]bombesin-(7–14) was conjugated through a linker to dye-functionalized superparamagnetic iron oxide nanoparticles for the development of a new potential magnetic resonance imaging probe. The peptide was conjugated via click chemistry, demonstrating a complementary alternative methodology to conventional peptide-nanoparticle conjugation strategies. The peptide-functionalized nanoparticles were then demonstrated to be selectively taken up by PC-3 prostate cancer cells relative to unfunctionalized nanoparticles and this uptake was inhibited by the presence of free peptide, confirming the specificity of the interaction. This study suggests that these nanoparticles have the potential to serve as magnetic resonance imaging probes for the detection of prostate cancer.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Alonzi R, Padhani AR, Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63:335–350CrossRefPubMed Alonzi R, Padhani AR, Allen C (2007) Dynamic contrast enhanced MRI in prostate cancer. Eur J Radiol 63:335–350CrossRefPubMed
Zurück zum Zitat American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta, p 54 American Cancer Society (2007) Cancer facts and figures 2007. American Cancer Society, Atlanta, p 54
Zurück zum Zitat Ametamey SM, Honer M, Schubiger PA (2008) Molecular imaging with PET. Chem Rev 108:1501–1516CrossRefPubMed Ametamey SM, Honer M, Schubiger PA (2008) Molecular imaging with PET. Chem Rev 108:1501–1516CrossRefPubMed
Zurück zum Zitat Baidoo KE, Lin KS, Zhan Y, Finley P, Scheffel U, Wagner HN Jr (1998) Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. Bioconjug Chem 9:218–225CrossRefPubMed Baidoo KE, Lin KS, Zhan Y, Finley P, Scheffel U, Wagner HN Jr (1998) Design, synthesis, and initial evaluation of high-affinity technetium bombesin analogues. Bioconjug Chem 9:218–225CrossRefPubMed
Zurück zum Zitat Basilion JP, Yeon S, Botnar R (2005) Magnetic resonance imaging: utility as a molecular imaging modality. Curr Top Dev Biol 70:1–33CrossRefPubMed Basilion JP, Yeon S, Botnar R (2005) Magnetic resonance imaging: utility as a molecular imaging modality. Curr Top Dev Biol 70:1–33CrossRefPubMed
Zurück zum Zitat Broccardo M, Falconieri Erspamer G, Melchiorri P, Negri L (1975) Relative potency of bombesin-like peptides. Br J Pharmacol 5:221–227 Broccardo M, Falconieri Erspamer G, Melchiorri P, Negri L (1975) Relative potency of bombesin-like peptides. Br J Pharmacol 5:221–227
Zurück zum Zitat Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99:2293–2352CrossRefPubMed Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium (III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99:2293–2352CrossRefPubMed
Zurück zum Zitat Chodak GW, Keller P, Schoenberg HW (1989) Assessment of screening for prostate cancer using the digital rectal exam. J Urol 141:1136–1138 Chodak GW, Keller P, Schoenberg HW (1989) Assessment of screening for prostate cancer using the digital rectal exam. J Urol 141:1136–1138
Zurück zum Zitat Girard F, Bachelard H, St-Pierre S, Rioux F (1984) The contractile effect of bombesin, gastrin releasing peptide and various fragments in the rat stomach strip. Eur Pharmacol 102:489–497CrossRef Girard F, Bachelard H, St-Pierre S, Rioux F (1984) The contractile effect of bombesin, gastrin releasing peptide and various fragments in the rat stomach strip. Eur Pharmacol 102:489–497CrossRef
Zurück zum Zitat Heijmink SW, Futterer JJ, Hambrock T, Takahashi S, Scheenen TWJ, Huisman HJ, Hulsbergen-Van de Kaa CA, Knipscheer BC, Kiemeney LAL, Witjes JA, Barentsz JO (2007) Prostate cancer: Body-array versus endorectal coil MR imaging at 3 T—comparison of image quality, localization, and staging performance. Radiology 244:184–195CrossRefPubMed Heijmink SW, Futterer JJ, Hambrock T, Takahashi S, Scheenen TWJ, Huisman HJ, Hulsbergen-Van de Kaa CA, Knipscheer BC, Kiemeney LAL, Witjes JA, Barentsz JO (2007) Prostate cancer: Body-array versus endorectal coil MR imaging at 3 T—comparison of image quality, localization, and staging performance. Radiology 244:184–195CrossRefPubMed
Zurück zum Zitat Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA (2003) Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nuc Med 44:823–831 Hoffman TJ, Gali H, Smith CJ, Sieckman GL, Hayes DL, Owen NK, Volkert WA (2003) Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells. J Nuc Med 44:823–831
Zurück zum Zitat Hosseinkhani H, Hosseinkhani M (2009) Biodegradable polymer-metal complexes for gene and drug delivery. Curr Drug Safety 4:79–83CrossRef Hosseinkhani H, Hosseinkhani M (2009) Biodegradable polymer-metal complexes for gene and drug delivery. Curr Drug Safety 4:79–83CrossRef
Zurück zum Zitat Huzjan R, Sala E, Hricak H (2005) Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer. Nat Clin Prac Urol 2:434–442CrossRef Huzjan R, Sala E, Hricak H (2005) Magnetic resonance imaging and magnetic resonance spectroscopic imaging of prostate cancer. Nat Clin Prac Urol 2:434–442CrossRef
Zurück zum Zitat Ikonen S, Karkkainen P, Kivisaari L, Salo JO, Taari K, Vehmas T, Tervahartiala P, Rannikko S (2001) Endorectal magnetic resonance imaging of prostatic cancer: Comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 11:236–241CrossRefPubMed Ikonen S, Karkkainen P, Kivisaari L, Salo JO, Taari K, Vehmas T, Tervahartiala P, Rannikko S (2001) Endorectal magnetic resonance imaging of prostatic cancer: Comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences. Eur Radiol 11:236–241CrossRefPubMed
Zurück zum Zitat Jobsis FF (1977) Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 198:1264–1267CrossRefPubMedADS Jobsis FF (1977) Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science 198:1264–1267CrossRefPubMedADS
Zurück zum Zitat Josephson L, Tung C, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186–191CrossRefPubMed Josephson L, Tung C, Moore A, Weissleder R (1999) High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 10:186–191CrossRefPubMed
Zurück zum Zitat Jun Y, Lee J, Cheon J (2008) Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed Engl 47:5122–5135CrossRefPubMed Jun Y, Lee J, Cheon J (2008) Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed Engl 47:5122–5135CrossRefPubMed
Zurück zum Zitat Kelly KA, Setlur S, Ross R, Anbazhagan R, Waterman P, Rubin MA, Weissleder R (2008) Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res 68:2286–2291CrossRefPubMed Kelly KA, Setlur S, Ross R, Anbazhagan R, Waterman P, Rubin MA, Weissleder R (2008) Detection of early prostate cancer using a hepsin-targeted imaging agent. Cancer Res 68:2286–2291CrossRefPubMed
Zurück zum Zitat Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50:1163–1174CrossRefPubMed Kirkham AP, Emberton M, Allen C (2006) How good is MRI at detecting and characterising cancer within the prostate? Eur Urol 50:1163–1174CrossRefPubMed
Zurück zum Zitat Kolb HC, Sharpless KB (2003) The growing impact of click chemistry on drug discovery. Drug Disc Today 8:1128–1137CrossRef Kolb HC, Sharpless KB (2003) The growing impact of click chemistry on drug discovery. Drug Disc Today 8:1128–1137CrossRef
Zurück zum Zitat La Bella R, Garcia-Garayoa E, Bahler M, Blauenstein P, Schibli R, Conrath P, Tourwe D, Schibiger PA (2002) A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjug Chem 13:599–604CrossRefPubMed La Bella R, Garcia-Garayoa E, Bahler M, Blauenstein P, Schibli R, Conrath P, Tourwe D, Schibiger PA (2002) A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjug Chem 13:599–604CrossRefPubMed
Zurück zum Zitat Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110CrossRefPubMed Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110CrossRefPubMed
Zurück zum Zitat Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H (2006) Viral nanoparticles as tools for intravital vascular imaging. Nat Med 12:354–360CrossRefPubMed Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H (2006) Viral nanoparticles as tools for intravital vascular imaging. Nat Med 12:354–360CrossRefPubMed
Zurück zum Zitat Lutz J, Zarafshani Z (2008) Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne “click” chemistry. Adv Drug Deliv Rev 60:958–970CrossRefPubMed Lutz J, Zarafshani Z (2008) Efficient construction of therapeutics, bioconjugates, biomaterials and bioactive surfaces using azide-alkyne “click” chemistry. Adv Drug Deliv Rev 60:958–970CrossRefPubMed
Zurück zum Zitat Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH, Jensen RT (1997) Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which deomonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem 272:26062–26071CrossRefPubMed Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH, Jensen RT (1997) Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which deomonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors. J Biol Chem 272:26062–26071CrossRefPubMed
Zurück zum Zitat Martin AL, Bernas L, Foster PF, Rutt BK, Gillies ER (2008) Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. Bioconjug Chem 19:2375–2384CrossRefPubMed Martin AL, Bernas L, Foster PF, Rutt BK, Gillies ER (2008) Enhanced cell uptake of superparamagnetic iron oxide nanoparticles functionalized with dendritic guanidines. Bioconjug Chem 19:2375–2384CrossRefPubMed
Zurück zum Zitat Molday RS, MacKenzie D (1982) Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 52:353–367CrossRefPubMed Molday RS, MacKenzie D (1982) Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J Immunol Methods 52:353–367CrossRefPubMed
Zurück zum Zitat Montet X, Weissleder R, Josephson L (2006) Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem 17:905–911CrossRefPubMed Montet X, Weissleder R, Josephson L (2006) Imaging pancreatic cancer with a peptide-nanoparticle conjugate targeted to normal pancreas. Bioconjug Chem 17:905–911CrossRefPubMed
Zurück zum Zitat Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MAS, Appu S, Loblaw AD, Sugar L, Narod SA, Kattan MW (2007) Assessing individual risk for prostate cancer. J Clin Oncol 25:3582–3588CrossRefPubMed Nam RK, Toi A, Klotz LH, Trachtenberg J, Jewett MAS, Appu S, Loblaw AD, Sugar L, Narod SA, Kattan MW (2007) Assessing individual risk for prostate cancer. J Clin Oncol 25:3582–3588CrossRefPubMed
Zurück zum Zitat Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE (2000) Dynamic contrast enhanced MRI of prostate cancer:correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99–109CrossRefPubMed Padhani AR, Gapinski CJ, Macvicar DA, Parker GJ, Suckling J, Revell PB, Leach MO, Dearnaley DP, Husband JE (2000) Dynamic contrast enhanced MRI of prostate cancer:correlation with morphology and tumour stage, histological grade and PSA. Clin Radiol 55:99–109CrossRefPubMed
Zurück zum Zitat Patel O, Shulkes A, Baldwin GS (2006) Gastrin releasing peptide and cancer. Biochim Biophys Acta 1766:23–41PubMed Patel O, Shulkes A, Baldwin GS (2006) Gastrin releasing peptide and cancer. Biochim Biophys Acta 1766:23–41PubMed
Zurück zum Zitat Pittet MJ, Swirski PK, Reynolds F, Josephson L, Weissleder R (2006) Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nat Protoc 1:73–78CrossRefPubMed Pittet MJ, Swirski PK, Reynolds F, Josephson L, Weissleder R (2006) Labeling of immune cells for in vivo imaging using magnetofluorescent nanoparticles. Nat Protoc 1:73–78CrossRefPubMed
Zurück zum Zitat Pradhan TK, Katsuno T, Taylor JE, Kim SH, Ryan RR, Mantey SA, Donohue PJ, Weber HC, Sainz E, Battey JF, Coy DH, Jensen RT (1998) Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur J Pharm 343:275–287CrossRef Pradhan TK, Katsuno T, Taylor JE, Kim SH, Ryan RR, Mantey SA, Donohue PJ, Weber HC, Sainz E, Battey JF, Coy DH, Jensen RT (1998) Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes. Eur J Pharm 343:275–287CrossRef
Zurück zum Zitat Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gigger M (2002) Bombesin receptor subtypes in human cancers: Detection with the universal radioligand I-125-[D-TYR6, beta-ALA(11), PHE13, NLE14] bombesin(6-14). Clin Cancer Res 8:1139–1146PubMed Reubi JC, Wenger S, Schmuckli-Maurer J, Schaer JC, Gigger M (2002) Bombesin receptor subtypes in human cancers: Detection with the universal radioligand I-125-[D-TYR6, beta-ALA(11), PHE13, NLE14] bombesin(6-14). Clin Cancer Res 8:1139–1146PubMed
Zurück zum Zitat Reynolds F, Weissleder R, Josephson L (2005) Protamine as an efficient membrane-translocating peptide. Bioconjug Chem 16:1240–1245CrossRefPubMed Reynolds F, Weissleder R, Josephson L (2005) Protamine as an efficient membrane-translocating peptide. Bioconjug Chem 16:1240–1245CrossRefPubMed
Zurück zum Zitat Rogers BE, Bigott HM, McCarthy DW, Della Manna D, Kim J, Sharp TL, Welch MJ (2003) MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjug Chem 14:756–763CrossRefPubMed Rogers BE, Bigott HM, McCarthy DW, Della Manna D, Kim J, Sharp TL, Welch MJ (2003) MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue. Bioconjug Chem 14:756–763CrossRefPubMed
Zurück zum Zitat Serada RE, Adolphi NL, Bisoffi M, Sillerud LO (2007) Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging 6:277–288 Serada RE, Adolphi NL, Bisoffi M, Sillerud LO (2007) Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging 6:277–288
Zurück zum Zitat Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, Volkert WA, Hoffman TJ (2003) Radiochemical investigations of gastrin-releasing peptide receptor-specific [99mTc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2] in PC-3, tumor-bearing rodent models; syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2, 3-diaminopropionic acid and X = H2O or P(CH2OH)3. Cancer Res 63:4082–4088PubMed Smith CJ, Sieckman GL, Owen NK, Hayes DL, Mazuru DG, Kannan R, Volkert WA, Hoffman TJ (2003) Radiochemical investigations of gastrin-releasing peptide receptor-specific [99mTc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2] in PC-3, tumor-bearing rodent models; syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2, 3-diaminopropionic acid and X = H2O or P(CH2OH)3. Cancer Res 63:4082–4088PubMed
Zurück zum Zitat Song HT, Choi JS, Huh YM, Kim S, Jun YW, Suh JS, Cheon J (2005) Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J Am Chem Soc 127:9992–9993CrossRefPubMed Song HT, Choi JS, Huh YM, Kim S, Jun YW, Suh JS, Cheon J (2005) Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. J Am Chem Soc 127:9992–9993CrossRefPubMed
Zurück zum Zitat Sun B, Schally AV, Halmos G (2000) The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial Cancers. Regul Pept 90:77–84CrossRefPubMed Sun B, Schally AV, Halmos G (2000) The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial Cancers. Regul Pept 90:77–84CrossRefPubMed
Zurück zum Zitat Sun EY, Josephson L, Weissleder R (2006) “Clickable” nanoparticles for targeted imaging. Mol Imaging 5:122–128PubMed Sun EY, Josephson L, Weissleder R (2006) “Clickable” nanoparticles for targeted imaging. Mol Imaging 5:122–128PubMed
Zurück zum Zitat Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: The clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152CrossRefPubMed Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S (2007) Prostate cancer screening: The clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 25:146–152CrossRefPubMed
Zurück zum Zitat Van de Wiele C, Dumont F, Vanden Broecke R, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thronback J, Slegers G, Dierckx RA (2000) Technetium-99m RP527, a GRP analogue for visualization of GRP receptor-expressing malignancies: a feasibility study. Eur J Nuc Med 27:1694–1699CrossRef Van de Wiele C, Dumont F, Vanden Broecke R, Oosterlinck W, Cocquyt V, Serreyn R, Peers S, Thronback J, Slegers G, Dierckx RA (2000) Technetium-99m RP527, a GRP analogue for visualization of GRP receptor-expressing malignancies: a feasibility study. Eur J Nuc Med 27:1694–1699CrossRef
Zurück zum Zitat Van de Wiele CV, Dumont F, Dierckx RA, Peers SH, Thornback JR, Slegers G (2001) Biodistribution and dosimetry of 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. J Nucl Med 42:1722–1727PubMed Van de Wiele CV, Dumont F, Dierckx RA, Peers SH, Thornback JR, Slegers G (2001) Biodistribution and dosimetry of 99mTc-RP527, a gastrin-releasing peptide (GRP) agonist for the visualization of GRP receptor-expressing malignancies. J Nucl Med 42:1722–1727PubMed
Zurück zum Zitat Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima MJ, Langer R, Kantoff PW, Bander NH, Jon S, Farokhzad OC (2008) Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem 3:1131–1315 Wang AZ, Bagalkot V, Vasilliou CC, Gu F, Alexis F, Zhang L, Shaikh M, Yuet K, Cima MJ, Langer R, Kantoff PW, Bander NH, Jon S, Farokhzad OC (2008) Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem 3:1131–1315
Zurück zum Zitat White MA, Johnson JA, Koberstein JT, Turro NJ (2006) Toward the syntheses of universal ligands for metal oxide surfaces: controlling surface functionality through click chemistry. J Am Chem Soc 128:11356–11357CrossRefPubMed White MA, Johnson JA, Koberstein JT, Turro NJ (2006) Toward the syntheses of universal ligands for metal oxide surfaces: controlling surface functionality through click chemistry. J Am Chem Soc 128:11356–11357CrossRefPubMed
Zurück zum Zitat Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591–607CrossRefPubMed Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591–607CrossRefPubMed
Zurück zum Zitat Zapotoczna A, Sasso G, Simpson J, Roach M (2007) Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer. Neoplasia 9:455–463CrossRefPubMed Zapotoczna A, Sasso G, Simpson J, Roach M (2007) Current role and future perspectives of magnetic resonance spectroscopy in radiation oncology for prostate cancer. Neoplasia 9:455–463CrossRefPubMed
Metadaten
Titel
Synthesis of bombesin-functionalized iron oxide nanoparticles and their specific uptake in prostate cancer cells
verfasst von
Amanda L. Martin
Jennifer L. Hickey
Amber L. Ablack
John D. Lewis
Leonard G. Luyt
Elizabeth R. Gillies
Publikationsdatum
01.06.2010
Verlag
Springer Netherlands
Erschienen in
Journal of Nanoparticle Research / Ausgabe 5/2010
Print ISSN: 1388-0764
Elektronische ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-009-9681-3

Weitere Artikel der Ausgabe 5/2010

Journal of Nanoparticle Research 5/2010 Zur Ausgabe

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.